Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Ranging Study of Tolperisone in Acute Muscle Spasm of the Back
NCT03802565Phase 2Completed
- Sponsor
- Neurana Pharmaceuticals, Inc.
- Start
- Feb 2019
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tolperisone in acute lumbago, Muscle spasm, sponsored by Neurana Pharmaceuticals, Inc.. Started Feb 2019; status: completed.
02
Drugs
tolperisone
03
Conditions
acute lumbagoMuscle spasm
Beyond the preview
Go deeper on NCT03802565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03802565.